Chembio Diagnostics Receives Food and Drug Administration contingency Utilize Authorization for the premier Rapid Zika virus IgM Test

The DPP® Zika virus System includes the DPP® Zika virus IgM Assay & DPP® Micro Reader, that is portable, hand-held, simple to use, & could lower the danger of human error during Analysis interpretation. The DPP® Zika virus System Uses the patented technology platform used in the Company's Food and Drug Administration confirmed & CLIA waived DPP® HIV virus 1/2 Assay. Each of Chembio Diagnostic Systems, company & Chembio Diagnostics Malaysia Sdn. Forward-looking statements involve statements regarding the intent, belief or current expectations of the Company & its management. Contacts:Vida Strategic PartnersStephanie C. Diaz (investor relations)(415) 675-7401sdiaz@vidasp.comTim Brons (media)(415) 675-7402tbrons@vidasp.comSource: Chembio Diagnostics, Inc.

CDC Is Deactivating the contingency Operations Center for the Zika virus Response

CDC going to still its work to protect these groups by providing backing for healthcare providers as they counsel pregnant ladies influenced by Zika virus & provide follow-up care to their infants. Zika continues to be a public health menace in the U.S. & internationally. As a reminder, Centers for Disease Control and Prevention recommends travelers to areas by a danger of Zika virus take steps to protect Zika virus by protecting mosquito bites & sexual commute of Zika virus during & after travel. CDC continues to recommend which pregnant ladies avert travel to areas by danger of Zika. CDC is headquartered in Atlanta & has Specialists located throughout the U.S. & the world.

Chembio Zika virus Analysis Gets Food and Drug Administration contingency Utilize Authorization

As it stated in NEW YORK (360Dx) – Chembio Diagnostics said today it has received America FDA contingency Utilize authorization (EUA) for its DPP Zika System. The authorization makes the Analysis obtainable for Utilize in high- & moderate-complexity CLIA-certified laboratories. Under the EUA, the diagnostic could be used to Analysis subjects meeting CDC Zika clinical and/or epidemiological criteria. The system Utilizes the company's DPP Micro Reader to announce Zika IgM antibodies in fingerstick whole blood.

collected by :Lucy William